Skip to main content
. Author manuscript; available in PMC: 2020 Jun 3.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2012 Nov 13;5(6):750–758. doi: 10.1161/CIRCOUTCOMES.112.967406

Table 1.

Demographic and Baseline Characteristics by Treatment Groupa

Characteristic Mean (SD) P Value
TM
(n = 99)a
HE
(n = 102)a
Female participants 41.4 44.1 .70
Age, y 59.9 (10.7) 58.4 (10.5) .30
Lipid-lowering medication 59.6 60.8 .86
ACE inhibitors 43.4% 45.1% .81
Angiotensin receptor agonists 7.1% 6.9% .95
Beta blockers 2.0% 2.0% .98
Calcium channel blockers 34.3% 36.3% .77
Diuretics 43.4% 46.1% .71
Aspirin 41.4% 31.4% .14
Married 32.7 26.5 .34
Education, y 11.3 (2.7) 9.9 (3.6) .003**
Household Income, $ 16,979 (17,807) 14,194 (15, 023) .25
Income below $10 000 48.5 47.1 .84
Weight, kg 93.1 (19.4) 92.6 (24.0) .87
BMI 32.2 (6.8) 32.7 (7.4) .56
Stenosed Arteries, No. 1.8 (0.9) 1.8 (0.9) .91
Systolic blood pressure, mm Hg 133.0 (18.7) 131.5 (18.0) .57
Diastolic blood pressure, mm Hg 77.5 (12.3) 76.8 (11.4) .68
Hypertensive (BP≥140/90 mm Hg) 39.4 35.3 .55
Heart rate, bpm 72.0 (10.1) 72.2 (9.6) .89
Currently smoke 38.4 43.1 .49
Consume alcohol 30.3 28.4 .77
Use illicit drugs 4.0 4.9 .77
Moderate or vigorous physical activity, hr/d 4.4 (4.0) 4.9 (4.0) .41
Anger expression 26.0 (11.9) 28.5 (11.3) .14
CMHI 15.2 (5.1) 15.9 (5.3) .38
CES-D 18.2 30.7 .04*
Treatment expectancy 3.5 (0.9) 3.7 (0.9) .36

P-value column needs to be deleted and replaced by footnotes:

*

P<.05

**

P<.01

**

P<.001

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CES-D, Center for Epidemiological Studies Depression Scale35,36; CMHI, Cook-Medley Hostility Inventory composite score37,38; HE, health education control group; TM, Transcendental Meditation program.

a

For continuous variables, data are expressed as mean (SD) values; for dichotomous variables, data are expressed as percentage of patients.